Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
Clinical trial NCT06714864 · RECRUITING
Trial details
- NCT number
- NCT06714864
- Sponsor
- CorMedix Therapeutics
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-08
- Primary completion
- 2028-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.